Literature DB >> 6277444

Prenatal prediction of alpha-thalassemia phenotype by endonuclease mapping of parental DNA.

U P Steinbrecher, Y W Kan, N K de Leeuw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277444      PMCID: PMC1862954     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Identification of a nondeletion defect in alpha-thalassemia.

Authors:  Y W Kan; A M Dozy; R Trecartin; D Todd
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

2.  alpha-Globin gene organisation in blacks precludes the severe form of alpha-thalassaemia.

Authors:  A M Dozy; Y W Kan; S H Embury; W C Mentzer; W C Wang; B Lubin; J R Davis; H M Koenig
Journal:  Nature       Date:  1979-08-16       Impact factor: 49.962

Review 3.  Thalassemia.

Authors:  D G Nathan
Journal:  N Engl J Med       Date:  1972-03-16       Impact factor: 91.245

4.  The thalassaemia syndromes in Nigeria.

Authors:  G J Esan
Journal:  Br J Haematol       Date:  1970-07       Impact factor: 6.998

5.  A new genetic basis for hemoglobin-H disease.

Authors:  L Pressley; D R Higgs; J B Clegg; R P Perrine; M E Pembrey; D J Weatherall
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

6.  Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation.

Authors:  Y W Kan; A M Dozy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

7.  Prenatal diagnosis of alpha-thalassemia. Clinical application of molecular hybridization.

Authors:  Y W Kan; M S Golbus; A M Dozy
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

8.  Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion.

Authors:  S H Orkin; B P Alter; C Altay; M J Mahoney; H Lazarus; J C Hobbins; D G Nathan
Journal:  N Engl J Med       Date:  1978-07-27       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.